Back to
HHLR ADVISORS, LTD.
TNGX
Showing 0 of 4 quarters
Position history for
HHLR ADVISORS, LTD.'s holdings in TANGO THERAPEUTICS INC
No. HHLR Advisors exited its TNGX (Tango Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 882,088 shares worth $6.7M. HHLR Advisors already held TNGX in its Q3 2021 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.